Last reviewed · How we verify
NCT03375853: CC
Computerized Response Training Obesity Treatment
NA trial testing Computer Based Response Training Weight Loss Intervention in Obesity in 179 participants. Completed in 15 September 2023.
31 August 2023
Quick facts
| Lead sponsor | Oregon Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 179 |
| Start date | 15 July 2017 |
| Primary completion | 31 August 2023 |
| Estimated completion | 15 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Computer Based Response Training Weight Loss Intervention
- Generic Response Training Control Intervention
Conditions studied
- Obesity — all drugs for Obesity →
- Hyperphagia — all drugs for Hyperphagia →
- Feeding and Eating Disorders — all drugs for Feeding and Eating Disorders →
Sponsor
Oregon Research Institute
Who can join
Adults 18 to 38, any sex, with Obesity or Hyperphagia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will test whether a food response training intervention produces lasting body fat loss, use objective brain imaging to examine the mechanism of effect of this treatment and investigate the generalizability of the training to non-training foods, and examine factors that should amplify intervention effects to provide a test of the intervention theory. This novel treatment represents a bottom-up implicit training intervention that does not rely on executive control, prolonged caloric deprivation, and expensive clinicians to deliver, like behavioral weight loss treatments that have not produced lasting weight loss. If this computer-based response training intervention produces sustained body fat loss in overweight individuals, it could be easily implemented very broadly at almost no expense, addressing a leading public health problem.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obesity.
Metzendorf MI, Wieland LS, Richter B. · · 2024 · cited 28× · PMID 38375882 · DOI 10.1002/14651858.cd013591.pub2 -
Efficacy of a food response and attention training treatment for obesity: A randomized placebo controlled trial.
Stice E, Yokum S, Gau J, Veling H, et al · · 2022 · cited 12× · PMID 36058135 · DOI 10.1016/j.brat.2022.104183 -
Test-retest reliability of functional MRI food receipt, anticipated receipt, and picture tasks.
Yokum S, Bohon C, Berkman E, Stice E. · · 2021 · cited 7× · PMID 33851199 · DOI 10.1093/ajcn/nqab096 -
Relation of BOLD response to food-specific and generic motor response inhibition tasks to body fat gain in adults with overweight and obesity.
Yokum S, Stice E. · · 2023 · cited 3× · PMID 37094746 · DOI 10.1016/j.physbeh.2023.114206
Verify or expand the search:
- PubMed search for NCT03375853
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Oregon Research Institute trials
Trials by the same sponsor.
- NCT06306287 — Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use · NA · recruiting
- NCT05822466 — Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults · NA · recruiting
- NCT05725668 — A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment · NA · recruiting
- NCT05437809 — Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods · NA · recruiting
- NCT05142384 — ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03375853 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oregon Research Institute
- Last refreshed: 26 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03375853.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing